“Global Immunochemistry Reagents, Analyzers and Test Kits market set to grow to $34bn by 2024” says Visiongain report

01 October 2019
Pharma

Visiongain has launched a new pharma report Global Immunochemistry Reagents, Analyzers and Test Kits Market 2019-2029: Reagents and Test Kits, Analyzers, Disease Specific Tests, Rapid Tests, Drugs of Abuse/Toxicology Tests, Endocrinology Tests, Therapeutic Drug Monitoring Tests, Anemia/Vitamin Tests, Allergic Blood Tests, Autoimmune Diseases, Cardiac Markers, Infectious Diseases, Tumor Markers, Chemiluminescence Analyzers, ELISA Analyzers, Immunofluorescence Analyzers, Radioimmunoassay Analyzers.

Immunochemistry technologies have evolved significantly over the years and now offer critical testing in all areas. High incidences of cancer, infectious diseases and cardiovascular diseases globally will fuel the demand for better disease specific immunochemistry tests.

The lead analyst of the report commented "Established markets such as the US and Western Europe dominate the global immunochemistry market. However, these markets are restrained by reduced healthcare budgets and increased regulatory pressures on device development and approval, which now requires evidence of clinical cost-effectiveness before approval is given.

There is therefore more opportunity for market penetration and larger sales volumes in emerging countries, such as India and China, as these countries remain relatively under penetrated and their diagnostic testing markets offer huge opportunities, especially with the vast population pool."

Leading companies featured in the report include Abbott, bioMerieux, Danaher, Fujirebio, Ortho Clinical Diagnostics, Roche, Siemens, Sysmex Corporation, Thermo Fisher Scientific, Trivitron Healthcare Pvt. Ltd. and other companies.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 207 336 6100.

About Visiongain
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

“Biological Drug API Manufacturing market set to grow to $11bn by 2025” says Visiongain report

Strengths in the biotech contract manufacturing market, from the perspective of the CMOs, stem from the demand for lower cost manufacturing from companies of all sizes.

07 November 2019

Read

“global radiation oncology market is anticipated to surpass USD 6.5 billion by 2020”, says Visiongain

Growing aging population, urbanization, and growing wealth in low- and middle-income countries such as China and India are anticipated to boost the APAC radiation oncology market.

07 November 2019

Read

“Global Rabies Diagnostics Market is anticipated to surpass USD 1.8 billion by 2020”, says Visiongain

Several international healthcare organizations are working with healthcare organizations to develop and market new detection assays to drive efforts aimed at fighting the disease.

07 November 2019

Read

“Global spinal muscular atrophy (SMA) market is anticipated is to surpass USD 950 Million by 2020”, says Visiongain

Increasing awareness of SMA and increasing numbers of programs to expand treatment options for rare diseases are key factors that are boosting the market growth.

07 November 2019

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever